| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| MicroRNAs | 32 | 2020 | 1787 | 6.89 | Why? |
| Cell Movement | 13 | 2019 | 695 | 3.69 | Why? |
| Gene Expression Regulation, Neoplastic | 23 | 2019 | 1014 | 3.02 | Why? |
| Basic-Leucine Zipper Transcription Factors | 4 | 2019 | 19 | 2.96 | Why? |
| Cell Proliferation | 18 | 2019 | 1973 | 2.67 | Why? |
| Biomarkers, Tumor | 9 | 2019 | 1314 | 2.54 | Why? |
| Gene Silencing | 5 | 2018 | 213 | 2.25 | Why? |
| Apoptosis | 22 | 2019 | 2335 | 2.03 | Why? |
| RNA, Small Interfering | 8 | 2019 | 817 | 1.71 | Why? |
| Breast Neoplasms | 10 | 2019 | 3633 | 1.54 | Why? |
| Cell Line, Tumor | 19 | 2020 | 3608 | 1.45 | Why? |
| Neoplasms | 18 | 2019 | 17251 | 1.42 | Why? |
| Spondylitis, Ankylosing | 3 | 2018 | 231 | 1.34 | Why? |
| Carcinogenesis | 6 | 2019 | 236 | 1.30 | Why? |
| Drug Resistance, Neoplasm | 8 | 2019 | 447 | 1.28 | Why? |
| Proto-Oncogene Proteins c-akt | 3 | 2019 | 372 | 1.27 | Why? |
| Plant Extracts | 4 | 2018 | 1514 | 1.26 | Why? |
| Neoplasm Metastasis | 7 | 2019 | 682 | 1.26 | Why? |
| Antineoplastic Agents, Phytogenic | 3 | 2018 | 183 | 1.20 | Why? |
| Down-Regulation | 8 | 2020 | 1416 | 1.09 | Why? |
| Neoplasm Invasiveness | 6 | 2018 | 582 | 1.08 | Why? |
| Signal Transduction | 16 | 2021 | 7207 | 0.98 | Why? |
| Genes, Tumor Suppressor | 3 | 2018 | 43 | 0.98 | Why? |
| Tumor Microenvironment | 4 | 2018 | 264 | 0.94 | Why? |
| Tumor Suppressor Protein p53 | 3 | 2018 | 310 | 0.90 | Why? |
| Urtica dioica | 2 | 2017 | 12 | 0.89 | Why? |
| Neoplastic Stem Cells | 2 | 2018 | 120 | 0.86 | Why? |
| Neoplasms, Squamous Cell | 1 | 2019 | 6 | 0.83 | Why? |
| Immune System | 3 | 2019 | 1479 | 0.83 | Why? |
| HMGA2 Protein | 1 | 2019 | 2 | 0.81 | Why? |
| Doxorubicin | 2 | 2019 | 313 | 0.80 | Why? |
| Organometallic Compounds | 2 | 2019 | 206 | 0.80 | Why? |
| Photosensitizing Agents | 2 | 2019 | 279 | 0.79 | Why? |
| Aminopeptidases | 2 | 2018 | 41 | 0.78 | Why? |
| Scrophularia | 1 | 2018 | 1 | 0.78 | Why? |
| Minor Histocompatibility Antigens | 2 | 2018 | 56 | 0.77 | Why? |
| Mentha piperita | 1 | 2018 | 6 | 0.77 | Why? |
| Chitosan | 2 | 2019 | 196 | 0.76 | Why? |
| Leukemia, Myelomonocytic, Acute | 1 | 2017 | 2 | 0.74 | Why? |
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2017 | 12 | 0.73 | Why? |
| Colorectal Neoplasms | 5 | 2019 | 1884 | 0.73 | Why? |
| Osteosarcoma | 1 | 2019 | 83 | 0.72 | Why? |
| Snail Family Transcription Factors | 1 | 2017 | 20 | 0.72 | Why? |
| Stomach Neoplasms | 3 | 2020 | 477 | 0.72 | Why? |
| Fibrosarcoma | 1 | 2017 | 9 | 0.70 | Why? |
| Mammary Neoplasms, Experimental | 1 | 2017 | 21 | 0.70 | Why? |
| Fanconi Anemia Complementation Group Proteins | 1 | 2017 | 3 | 0.70 | Why? |
| Liposomes | 2 | 2019 | 334 | 0.69 | Why? |
| Amyloid Precursor Protein Secretases | 1 | 2017 | 38 | 0.69 | Why? |
| RNA, Untranslated | 1 | 2018 | 140 | 0.68 | Why? |
| Micronutrients | 1 | 2021 | 310 | 0.67 | Why? |
| Etoposide | 1 | 2017 | 115 | 0.66 | Why? |
| Oils, Volatile | 1 | 2018 | 127 | 0.65 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 347 | 0.65 | Why? |
| Herbal Medicine | 1 | 2016 | 69 | 0.64 | Why? |
| Genetic Therapy | 2 | 2018 | 409 | 0.60 | Why? |
| Quercetin | 1 | 2019 | 297 | 0.59 | Why? |
| Bone Neoplasms | 1 | 2019 | 287 | 0.58 | Why? |
| Photochemotherapy | 2 | 2019 | 297 | 0.57 | Why? |
| Drug Delivery Systems | 3 | 2019 | 1365 | 0.57 | Why? |
| Autoantigens | 1 | 2017 | 388 | 0.56 | Why? |
| RNA, Messenger | 11 | 2019 | 5131 | 0.56 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.56 | Why? |
| Immunity | 4 | 2019 | 2651 | 0.55 | Why? |
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 290 | 0.54 | Why? |
| DNA Methylation | 2 | 2018 | 688 | 0.54 | Why? |
| Wound Healing | 1 | 2018 | 424 | 0.54 | Why? |
| Immunotherapy | 5 | 2019 | 2421 | 0.53 | Why? |
| Cell Cycle Checkpoints | 3 | 2019 | 126 | 0.53 | Why? |
| Neovascularization, Pathologic | 1 | 2017 | 305 | 0.53 | Why? |
| Indoles | 2 | 2019 | 1243 | 0.52 | Why? |
| Receptor Tyrosine Kinase-like Orphan Receptors | 3 | 2017 | 5 | 0.52 | Why? |
| Matrix Metalloproteinase 9 | 4 | 2019 | 211 | 0.52 | Why? |
| Myeloid-Derived Suppressor Cells | 1 | 2017 | 316 | 0.52 | Why? |
| Animals | 36 | 2019 | 78931 | 0.51 | Why? |
| Immune Tolerance | 2 | 2017 | 608 | 0.51 | Why? |
| Mouth Neoplasms | 1 | 2019 | 463 | 0.48 | Why? |
| Th17 Cells | 1 | 2017 | 657 | 0.47 | Why? |
| Pancreatic Neoplasms | 1 | 2018 | 609 | 0.44 | Why? |
| Lung Neoplasms | 5 | 2019 | 3228 | 0.44 | Why? |
| Urinary Bladder Neoplasms | 1 | 2017 | 614 | 0.43 | Why? |
| Cell Survival | 5 | 2019 | 1581 | 0.43 | Why? |
| Single-Chain Antibodies | 3 | 2017 | 259 | 0.41 | Why? |
| Autoimmunity | 1 | 2017 | 841 | 0.41 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.40 | Why? |
| Phytotherapy | 1 | 2016 | 743 | 0.39 | Why? |
| Lasers, Semiconductor | 2 | 2019 | 16 | 0.39 | Why? |
| PTEN Phosphohydrolase | 2 | 2019 | 70 | 0.36 | Why? |
| Melanoma | 1 | 2019 | 1229 | 0.36 | Why? |
| Mice, Inbred BALB C | 6 | 2018 | 5814 | 0.36 | Why? |
| Cell Surface Display Techniques | 3 | 2017 | 170 | 0.35 | Why? |
| Drug Resistance, Multiple | 2 | 2019 | 156 | 0.34 | Why? |
| Up-Regulation | 4 | 2019 | 2249 | 0.34 | Why? |
| Paclitaxel | 2 | 2018 | 124 | 0.34 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.33 | Why? |
| Alzheimer Disease | 1 | 2017 | 1020 | 0.33 | Why? |
| Caspase 3 | 2 | 2017 | 218 | 0.33 | Why? |
| Cyclopentanes | 2 | 2017 | 55 | 0.33 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.33 | Why? |
| Receptors, CXCR4 | 2 | 2017 | 83 | 0.33 | Why? |
| Skin Neoplasms | 2 | 2019 | 1679 | 0.31 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2017 | 1380 | 0.31 | Why? |
| Humans | 80 | 2021 | 930598 | 0.31 | Why? |
| Inflammation | 5 | 2021 | 13255 | 0.30 | Why? |
| Disease Progression | 4 | 2021 | 13580 | 0.29 | Why? |
| Transfection | 2 | 2019 | 864 | 0.29 | Why? |
| Prostatic Neoplasms | 1 | 2017 | 1637 | 0.28 | Why? |
| Autophagy | 4 | 2019 | 960 | 0.27 | Why? |
| MCF-7 Cells | 3 | 2017 | 199 | 0.25 | Why? |
| Interleukin-17 | 2 | 2018 | 602 | 0.25 | Why? |
| Dose-Response Relationship, Radiation | 2 | 2019 | 133 | 0.24 | Why? |
| Zinc Compounds | 2 | 2019 | 62 | 0.24 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2021 | 8843 | 0.23 | Why? |
| HCT116 Cells | 2 | 2018 | 83 | 0.23 | Why? |
| Tumor Cells, Cultured | 2 | 2018 | 254 | 0.23 | Why? |
| Isoindoles | 2 | 2019 | 195 | 0.22 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 92 | 0.22 | Why? |
| Epigenesis, Genetic | 2 | 2018 | 711 | 0.22 | Why? |
| Nanostructures | 2 | 2018 | 700 | 0.22 | Why? |
| Mice | 8 | 2018 | 21357 | 0.21 | Why? |
| Antineoplastic Agents, Immunological | 2 | 2018 | 830 | 0.21 | Why? |
| Inflammatory Bowel Diseases | 1 | 2017 | 3209 | 0.20 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.20 | Why? |
| Antigens, CD20 | 2 | 2017 | 105 | 0.20 | Why? |
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 43 | 0.20 | Why? |
| Flavonolignans | 1 | 2018 | 1 | 0.20 | Why? |
| Optical Phenomena | 1 | 2018 | 11 | 0.20 | Why? |
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 43 | 0.20 | Why? |
| Electrochemistry | 1 | 2018 | 26 | 0.19 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 100 | 0.19 | Why? |
| Protein Deglycase DJ-1 | 1 | 2018 | 6 | 0.19 | Why? |
| Proto-Oncogene Proteins c-sis | 1 | 2018 | 8 | 0.19 | Why? |
| Myoblasts | 1 | 2018 | 24 | 0.19 | Why? |
| Receptor, ErbB-2 | 2 | 2018 | 267 | 0.19 | Why? |
| Cell Division | 1 | 2018 | 136 | 0.19 | Why? |
| Docosahexaenoic Acids | 1 | 2020 | 145 | 0.18 | Why? |
| Antineoplastic Agents | 4 | 2020 | 3550 | 0.18 | Why? |
| Catalase | 1 | 2018 | 97 | 0.18 | Why? |
| Dimethyl Fumarate | 1 | 2018 | 116 | 0.18 | Why? |
| Immunomodulation | 2 | 2017 | 1472 | 0.18 | Why? |
| Pyrimidines | 2 | 2017 | 1557 | 0.18 | Why? |
| Caspase 9 | 1 | 2017 | 38 | 0.18 | Why? |
| U937 Cells | 1 | 2017 | 77 | 0.18 | Why? |
| Leishmania major | 1 | 2017 | 9 | 0.18 | Why? |
| Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 40 | 0.18 | Why? |
| bcl-2-Associated X Protein | 1 | 2017 | 45 | 0.18 | Why? |
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 88 | 0.17 | Why? |
| Nanoparticles | 3 | 2019 | 2040 | 0.17 | Why? |
| Cell Hypoxia | 1 | 2018 | 141 | 0.17 | Why? |
| Cell Growth Processes | 1 | 2017 | 12 | 0.17 | Why? |
| Receptor, IGF Type 1 | 1 | 2017 | 24 | 0.17 | Why? |
| Interleukin-23 | 1 | 2018 | 64 | 0.17 | Why? |
| Thiazolidinediones | 1 | 2017 | 70 | 0.17 | Why? |
| Adaptive Immunity | 2 | 2020 | 2585 | 0.17 | Why? |
| Deoxyglucose | 1 | 2017 | 14 | 0.17 | Why? |
| Dendrimers | 1 | 2018 | 104 | 0.17 | Why? |
| Cell Transformation, Neoplastic | 1 | 2018 | 191 | 0.17 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2019 | 243 | 0.17 | Why? |
| Cell Cycle | 1 | 2018 | 329 | 0.17 | Why? |
| Proto-Oncogene Proteins c-met | 1 | 2017 | 40 | 0.17 | Why? |
| Leishmaniasis, Cutaneous | 1 | 2017 | 48 | 0.17 | Why? |
| Vimentin | 1 | 2017 | 86 | 0.17 | Why? |
| PPAR gamma | 1 | 2017 | 102 | 0.16 | Why? |
| Toll-Like Receptor 2 | 1 | 2018 | 198 | 0.16 | Why? |
| Ki-67 Antigen | 1 | 2017 | 139 | 0.16 | Why? |
| Cadherins | 1 | 2017 | 145 | 0.16 | Why? |
| Genetic Predisposition to Disease | 4 | 2019 | 4027 | 0.16 | Why? |
| Immunoglobulin Light Chains | 1 | 2017 | 62 | 0.16 | Why? |
| Candida albicans | 1 | 2018 | 217 | 0.16 | Why? |
| Cloning, Molecular | 2 | 2017 | 1036 | 0.16 | Why? |
| Quinazolines | 1 | 2017 | 126 | 0.16 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2019 | 242 | 0.16 | Why? |
| Obesity, Abdominal | 1 | 2018 | 167 | 0.16 | Why? |
| Gene Expression Regulation | 3 | 2018 | 4020 | 0.16 | Why? |
| Hepatitis | 1 | 2018 | 160 | 0.16 | Why? |
| Reperfusion Injury | 1 | 2018 | 178 | 0.16 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2019 | 385 | 0.16 | Why? |
| Complementarity Determining Regions | 1 | 2017 | 147 | 0.15 | Why? |
| Drug Synergism | 1 | 2019 | 833 | 0.15 | Why? |
| Cyclophosphamide | 1 | 2018 | 387 | 0.15 | Why? |
| Gene Knockdown Techniques | 1 | 2017 | 347 | 0.15 | Why? |
| MAP Kinase Signaling System | 1 | 2018 | 360 | 0.15 | Why? |
| Glioblastoma | 1 | 2018 | 187 | 0.15 | Why? |
| Immunoglobulin Heavy Chains | 1 | 2017 | 222 | 0.15 | Why? |
| A549 Cells | 2 | 2018 | 2066 | 0.15 | Why? |
| Cell Differentiation | 2 | 2018 | 1338 | 0.15 | Why? |
| Histocompatibility Antigens Class I | 1 | 2020 | 624 | 0.15 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.15 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 334 | 0.14 | Why? |
| Genome, Human | 1 | 2018 | 400 | 0.14 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.14 | Why? |
| Aptamers, Nucleotide | 1 | 2018 | 265 | 0.14 | Why? |
| Toll-Like Receptor 4 | 1 | 2018 | 390 | 0.14 | Why? |
| Phosphorylation | 1 | 2018 | 1060 | 0.14 | Why? |
| DNA, Complementary | 1 | 2017 | 568 | 0.14 | Why? |
| Carrier Proteins | 1 | 2018 | 513 | 0.14 | Why? |
| Prognosis | 7 | 2021 | 32490 | 0.14 | Why? |
| Receptors, Immunologic | 1 | 2018 | 555 | 0.14 | Why? |
| Chemoradiotherapy | 1 | 2017 | 362 | 0.14 | Why? |
| Lymphocytes | 2 | 2018 | 3056 | 0.14 | Why? |
| Receptors, Interleukin-8A | 1 | 2013 | 3 | 0.14 | Why? |
| Molecular Targeted Therapy | 3 | 2018 | 1579 | 0.14 | Why? |
| Receptors, Interleukin-8B | 1 | 2013 | 36 | 0.13 | Why? |
| Biosensing Techniques | 2 | 2018 | 2116 | 0.13 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.13 | Why? |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 314 | 0.13 | Why? |
| Candidiasis | 1 | 2018 | 334 | 0.13 | Why? |
| Peptide Library | 1 | 2017 | 564 | 0.13 | Why? |
| Gene Frequency | 1 | 2018 | 1210 | 0.13 | Why? |
| Iran | 4 | 2021 | 5467 | 0.13 | Why? |
| Antibodies, Monoclonal | 4 | 2017 | 8041 | 0.13 | Why? |
| Autoimmune Diseases | 2 | 2018 | 1996 | 0.13 | Why? |
| Particle Size | 1 | 2019 | 1052 | 0.13 | Why? |
| NF-kappa B | 1 | 2021 | 1301 | 0.13 | Why? |
| Nanotechnology | 1 | 2019 | 821 | 0.12 | Why? |
| Female | 19 | 2021 | 380317 | 0.12 | Why? |
| L-Lactate Dehydrogenase | 1 | 2021 | 1995 | 0.12 | Why? |
| Leukemia | 1 | 2017 | 598 | 0.12 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2017 | 127 | 0.12 | Why? |
| Vitamins | 1 | 2021 | 1208 | 0.12 | Why? |
| Interferon-beta | 1 | 2018 | 979 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 1 | 2019 | 1063 | 0.11 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.11 | Why? |
| Th1 Cells | 1 | 2017 | 1228 | 0.11 | Why? |
| Administration, Oral | 1 | 2019 | 2340 | 0.11 | Why? |
| Interleukin-10 | 1 | 2018 | 1409 | 0.11 | Why? |
| Antibodies, Bispecific | 1 | 2013 | 207 | 0.11 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.10 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2021 | 2483 | 0.10 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.10 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.10 | Why? |
| Multiple Sclerosis | 2 | 2018 | 2600 | 0.10 | Why? |
| Inflammation Mediators | 2 | 2018 | 2654 | 0.10 | Why? |
| Metabolic Syndrome | 1 | 2018 | 810 | 0.10 | Why? |
| Immunity, Innate | 2 | 2018 | 6570 | 0.10 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2017 | 877 | 0.09 | Why? |
| Protein Kinase Inhibitors | 1 | 2019 | 1585 | 0.09 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.09 | Why? |
| Membrane Glycoproteins | 1 | 2018 | 2273 | 0.09 | Why? |
| Dietary Supplements | 1 | 2021 | 2251 | 0.09 | Why? |
| Risk | 2 | 2018 | 5288 | 0.09 | Why? |
| Drug Liberation | 2 | 2019 | 141 | 0.09 | Why? |
| Enzyme Inhibitors | 1 | 2018 | 1881 | 0.09 | Why? |
| Interferon-gamma | 1 | 2017 | 2711 | 0.08 | Why? |
| Hypersensitivity | 1 | 2018 | 1137 | 0.08 | Why? |
| Interleukin-8 | 1 | 2013 | 964 | 0.08 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.08 | Why? |
| Delayed-Action Preparations | 2 | 2019 | 291 | 0.08 | Why? |
| Neutrophils | 2 | 2021 | 5476 | 0.08 | Why? |
| Hematologic Neoplasms | 2 | 2017 | 2105 | 0.08 | Why? |
| Enzyme Activation | 2 | 2018 | 425 | 0.08 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.08 | Why? |
| Hybridomas | 2 | 2017 | 74 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2017 | 1666 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 7868 | 0.07 | Why? |
| B-Lymphocytes | 2 | 2017 | 4418 | 0.07 | Why? |
| Escherichia coli | 3 | 2017 | 1547 | 0.07 | Why? |
| Hydrogen-Ion Concentration | 2 | 2019 | 993 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.07 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.07 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.06 | Why? |
| Disease Models, Animal | 2 | 2018 | 10998 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.06 | Why? |
| Models, Theoretical | 1 | 2021 | 6659 | 0.06 | Why? |
| Gene Expression | 3 | 2017 | 3332 | 0.06 | Why? |
| Immunoglobulin A | 1 | 2014 | 3567 | 0.06 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.05 | Why? |
| Antibody Specificity | 2 | 2017 | 1328 | 0.05 | Why? |
| Mitochondria | 2 | 2018 | 857 | 0.05 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2017 | 5837 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Sodium-Calcium Exchanger | 1 | 2018 | 2 | 0.05 | Why? |
| Male | 9 | 2021 | 367725 | 0.05 | Why? |
| Biocatalysis | 1 | 2018 | 100 | 0.05 | Why? |
| Binding, Competitive | 1 | 2018 | 264 | 0.05 | Why? |
| Membrane Potential, Mitochondrial | 1 | 2018 | 102 | 0.05 | Why? |
| HLA-B27 Antigen | 1 | 2018 | 48 | 0.04 | Why? |
| K562 Cells | 1 | 2017 | 91 | 0.04 | Why? |
| Colony Count, Microbial | 1 | 2018 | 177 | 0.04 | Why? |
| RNA, Neoplasm | 1 | 2017 | 34 | 0.04 | Why? |
| Waist Circumference | 1 | 2018 | 199 | 0.04 | Why? |
| Caspase 8 | 1 | 2017 | 92 | 0.04 | Why? |
| Acute-Phase Proteins | 1 | 2018 | 177 | 0.04 | Why? |
| Radiation-Sensitizing Agents | 1 | 2016 | 16 | 0.04 | Why? |
| Membrane Microdomains | 1 | 2017 | 51 | 0.04 | Why? |
| Hepatocyte Growth Factor | 1 | 2017 | 71 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2017 | 335 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| Cullin Proteins | 1 | 2016 | 31 | 0.04 | Why? |
| NF-KappaB Inhibitor alpha | 1 | 2016 | 63 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Recombinant Proteins | 2 | 2017 | 3786 | 0.04 | Why? |
| Cough | 2 | 2020 | 4891 | 0.04 | Why? |
| Drug Therapy | 1 | 2018 | 280 | 0.04 | Why? |
| Necrosis | 1 | 2018 | 532 | 0.04 | Why? |
| Radiotherapy Dosage | 1 | 2017 | 428 | 0.04 | Why? |
| Lymphatic Metastasis | 1 | 2017 | 537 | 0.04 | Why? |
| STAT3 Transcription Factor | 1 | 2017 | 268 | 0.04 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Polymers | 1 | 2019 | 507 | 0.04 | Why? |
| Horseradish Peroxidase | 1 | 2014 | 14 | 0.04 | Why? |
| Injections, Intraperitoneal | 1 | 2014 | 69 | 0.03 | Why? |
| Colorimetry | 1 | 2018 | 458 | 0.03 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.03 | Why? |
| Blood Cell Count | 1 | 2020 | 1101 | 0.03 | Why? |
| Electrochemical Techniques | 1 | 2018 | 406 | 0.03 | Why? |
| Cattle | 1 | 2018 | 1336 | 0.03 | Why? |
| Sequence Homology, Amino Acid | 1 | 2017 | 945 | 0.03 | Why? |
| Cell Cycle Proteins | 1 | 2016 | 297 | 0.03 | Why? |
| Spleen | 1 | 2018 | 877 | 0.03 | Why? |
| Immunoconjugates | 1 | 2014 | 90 | 0.03 | Why? |
| Clone Cells | 1 | 2014 | 312 | 0.03 | Why? |
| Survival Rate | 2 | 2018 | 9206 | 0.03 | Why? |
| Fever | 2 | 2020 | 7795 | 0.03 | Why? |
| Calcium | 1 | 2018 | 708 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2017 | 604 | 0.03 | Why? |
| Drug Interactions | 1 | 2020 | 1653 | 0.03 | Why? |
| Luminescent Measurements | 1 | 2018 | 924 | 0.03 | Why? |
| Radiation Dosage | 1 | 2017 | 585 | 0.03 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.03 | Why? |
| Cell Line | 2 | 2018 | 12040 | 0.03 | Why? |
| Molecular Structure | 1 | 2017 | 1539 | 0.03 | Why? |
| Travel | 2 | 2020 | 7220 | 0.03 | Why? |
| Drug Carriers | 1 | 2017 | 590 | 0.03 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.03 | Why? |
| Sequence Alignment | 1 | 2017 | 2109 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2014 | 21571 | 0.02 | Why? |
| Genetic Vectors | 1 | 2017 | 1600 | 0.02 | Why? |
| Temperature | 1 | 2019 | 2305 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Rituximab | 1 | 2017 | 1096 | 0.02 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.02 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 11367 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.02 | Why? |
| Adult | 4 | 2018 | 244371 | 0.02 | Why? |
| Protein Conformation | 1 | 2018 | 4386 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Epithelial Cells | 1 | 2018 | 3508 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
| Peptides | 1 | 2017 | 2513 | 0.02 | Why? |
| Models, Molecular | 1 | 2018 | 7616 | 0.02 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.02 | Why? |
| Kidney | 1 | 2018 | 3648 | 0.02 | Why? |
| Protein Domains | 1 | 2017 | 6563 | 0.02 | Why? |
| China | 2 | 2021 | 50654 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2018 | 6902 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Cross Reactions | 1 | 2014 | 4374 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
| Aged | 1 | 2021 | 215776 | 0.00 | Why? |